Brain wave study tests potential drug for genetic disorder
NCT ID NCT06334419
Summary
This study tested a single dose of an experimental drug called gaboxadol in 10 adult men with Fragile X Syndrome, a genetic condition. Researchers wanted to see if the drug changed brain wave patterns and affected certain behaviors or thinking skills. Participants received the drug or a placebo during both home and clinic visits to compare settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.